Search research articles
Contact Us
Filters
Showing results (81-90 of 112) with videos related to
Page
of 12
Sort By:
FEBS Letters
|
February 3, 1997
Partial coverage of phospholipid model membranes with annexin V may completely inhibit their degradation by phospholipase A2
H Speijer, S W Jans, C P Reutelingsperger, et al.
Clinical Chemistry
|
March 3, 1999
Influence of age and sex and day-to-day and within-day biological variation on plasma concentrations of fatty acid-binding protein and myoglobin in healthy subjects
M M Pelsers, J P Chapelle, M Knapen, et al.
Thrombosis Et Diathesis Haemorrhagica
|
June 30, 1971
The evaluation of the two-stage prothrombin assay
H C Hemker, P W Hemker, K v d Torren, et al.
Acta Anaesthesiologica Scandinavica. Supplementum
|
January 1, 1997
Fatty acid-binding protein as marker of muscle injury: experimental findings and clinical application
J F Glatz, G J Van der Vusse, J G Maessen, et al.
Biophysical Journal
|
May 8, 1999
A new principle for rapid immunoassay of proteins based on in situ precipitate-enhanced ellipsometry
M Robers, I J Rensink, C E Hack, et al.
Brain Research. Molecular Brain Research
|
October 1, 1994
Expression of the growth-associated protein B-50/GAP43 via a defective herpes-simplex virus vector results in profound morphological changes in non-neuronal cells
J Verhaagen, W T Hermens, A B Oestreicher, et al.
British Heart Journal
|
June 1, 1979
Recognition and quantification of myocardial injury by means of plasma enzyme and isoenzyme activities after cardiac surgery
A van der Laarse, H A Davids, L Hollaar, et al.
The Journal of Biological Chemistry
|
September 5, 1992
Clustering of lipid-bound annexin V may explain its anticoagulant effect
H A Andree, M C Stuart, W T Hermens, et al.
Clinical Chemistry
|
February 1, 1996
Distribution of myoglobin and fatty acid-binding protein in human cardiac autopsies
J A Kragten, F A van Nieuwenhoven, M P van Dieijen-Visser, et al.
Circulation
|
July 7, 1999
C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?
W K Lagrand, C A Visser, W T Hermens, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 112) with videos related to
Sort By:
Page
of 12
FEBS Letters
|
February 3, 1997
Partial coverage of phospholipid model membranes with annexin V may completely inhibit their degradation by phospholipase A2
H Speijer, S W Jans, C P Reutelingsperger, et al.
Clinical Chemistry
|
March 3, 1999
Influence of age and sex and day-to-day and within-day biological variation on plasma concentrations of fatty acid-binding protein and myoglobin in healthy subjects
M M Pelsers, J P Chapelle, M Knapen, et al.
Thrombosis Et Diathesis Haemorrhagica
|
June 30, 1971
The evaluation of the two-stage prothrombin assay
H C Hemker, P W Hemker, K v d Torren, et al.
Acta Anaesthesiologica Scandinavica. Supplementum
|
January 1, 1997
Fatty acid-binding protein as marker of muscle injury: experimental findings and clinical application
J F Glatz, G J Van der Vusse, J G Maessen, et al.
Biophysical Journal
|
May 8, 1999
A new principle for rapid immunoassay of proteins based on in situ precipitate-enhanced ellipsometry
M Robers, I J Rensink, C E Hack, et al.
Brain Research. Molecular Brain Research
|
October 1, 1994
Expression of the growth-associated protein B-50/GAP43 via a defective herpes-simplex virus vector results in profound morphological changes in non-neuronal cells
J Verhaagen, W T Hermens, A B Oestreicher, et al.
British Heart Journal
|
June 1, 1979
Recognition and quantification of myocardial injury by means of plasma enzyme and isoenzyme activities after cardiac surgery
A van der Laarse, H A Davids, L Hollaar, et al.
The Journal of Biological Chemistry
|
September 5, 1992
Clustering of lipid-bound annexin V may explain its anticoagulant effect
H A Andree, M C Stuart, W T Hermens, et al.
Clinical Chemistry
|
February 1, 1996
Distribution of myoglobin and fatty acid-binding protein in human cardiac autopsies
J A Kragten, F A van Nieuwenhoven, M P van Dieijen-Visser, et al.
Circulation
|
July 7, 1999
C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?
W K Lagrand, C A Visser, W T Hermens, et al.
Page
of 12